January 19, 2023

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked
peer-reviewed publication
trusted source
proofread

Expert outlines hormone and nonhormonal therapies for menopause symptoms

Benefits and risks of the two hormone therapy formulations, conjugated equine estrogens (CEE) alone or in combination with medroxyprogesterone acetate (MPA), evaluated in the Women’s Health Initiative for women aged 50 to 59 years. Risks and benefits are expressed as the difference in number of events (number in the hormone therapy group minus the number in the placebo group) per 10,000 women per year, with <10 per 10,000 per year representing a rare event (dashed red line). Adapted from Manson JE, et al. Credit: Menopause (2022). DOI: 10.1097/GME.0000000000002028
× close
Benefits and risks of the two hormone therapy formulations, conjugated equine estrogens (CEE) alone or in combination with medroxyprogesterone acetate (MPA), evaluated in the Women’s Health Initiative for women aged 50 to 59 years. Risks and benefits are expressed as the difference in number of events (number in the hormone therapy group minus the number in the placebo group) per 10,000 women per year, with <10 per 10,000 per year representing a rare event (dashed red line). Adapted from Manson JE, et al. Credit: Menopause (2022). DOI: 10.1097/GME.0000000000002028

Menopause, the end of menstrual cycles, can produce symptoms such as hot flashes, night sweats, insomnia and mood changes. Women do not need to suffer in silence: Many treatment options are available. Jewel Kling, M.D., chair of the Division of Women's Health at Mayo Clinic in Scottsdale, Arizona, describes hormonal and nonhormonal therapies.

"We sometimes hear the question, 'Do I need to treat or night sweats?' and the answer for many may be, 'Yes,'" Dr. Kling says. "Because hot flashes and night sweats affect quality of life and productivity at work and at home for ."

Hormone replacement is an estrogen medication; for women with a uterus, typically includes estrogen plus progestogen medication to prevent . For women younger than 60 or within 10 years after their final period, the benefit of hormone therapy outweighs the risk in healthy women with postmenopausal symptoms, according to recent guidelines from the North American Menopause Society published in Menopause.

"Many factors affect a woman's decision whether to use hormones and if she uses them, which particular regimen is best to relieve her symptoms," Dr. Kling says. "Common factors considered include age, underlying health, symptom severity, preferences, available , and of course, cost considerations. One important consideration is whether the outweigh the potential risks."

Among benefits

Many studies have shown that systemic hormone therapy such as a pill, patch, gel or spray, helps with hot flashes, night sweats, and vulva vaginal symptoms, Dr. Kling says.

There's also strong evidence that long-term treatment with estrogen therapy or estrogen plus progestogen therapy reduce the risk of fractures after menopause.

"Along with these benefits often comes improvement with menopause-related symptoms, including those most likely bothersome, including disturbed sleep, mood problems, and diminished sexual satisfaction," Dr. Kling says. "Addressing these symptoms can lead to a better quality of life."

Among risks

With oral systemic or estrogen plus progestogen therapy, risks include in the legs and lungs, and stroke.

"Stroke is dependent on the age at which a woman starts hormone therapy. Specifically, the risks are low for women younger than 60 or within 10 years after their last period," Dr. Kling says. "There do not appear to be the same risks associated with transdermal estrogen products such as patches, particularly when we use lower doses."

"However, overall, the risk of serious events with hormone therapy are rare," Dr. Kling says. "For women with only vaginal symptoms, low-dose vaginal estrogen can be used. Low-dose vaginal estrogen does not have the same risks as systemic therapy because the body absorbs very little."

Hormone therapy generally isn't an option for women with breast cancer, other hormonally mediated cancers or blood clot issues, and other women may simply wish to avoid hormone therapy, Dr. Kling says. There are many nonhormonal therapies ranging from mind-body techniques to medication that can bring relief with few or no side effects:

"There are many ways to help women deal with the discomfort and diminished quality of life associated with menopause," Dr. Kling says. "Women don't need to simply tough it out. They can get help."

More information: The 2022 hormone therapy position statement of The North American Menopause Society, Menopause (2022). DOI: 10.1097/GME.0000000000002028

Journal information: Menopause

Provided by Mayo Clinic

Load comments (0)